arrow_back Back to App

Federal Ban on Contracts with Biotechnology Companies Posing National Security Risks.

This law aims to protect sensitive genetic and health data of US citizens by prohibiting federal agencies from entering into contracts or providing grants to specific biotechnology companies linked to foreign adversaries. This means government agencies and entities receiving federal funds must stop using equipment and services from companies designated as national security threats. The primary goal is to secure American research and medical infrastructure against espionage and unauthorized data access.
Key points
Federal agencies are banned from procuring equipment or services from designated "biotechnology companies of concern" (e.g., BGI, WuXi AppTec).
Federal loan or grant money cannot be used by recipients to purchase or use services from these banned companies.
The ban is designed to safeguard US citizens' genetic and health data (multiomic data) from foreign adversaries.
Transition periods and specific waivers (e.g., for overseas healthcare) are included to manage the shift away from existing contracts.
article Official text account_balance Process page
VOTING RESULTS
2024-09-09
79%
For 306
Against 81
Abstain 0
Full voting results open_in_new
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_8333
Sponsor: Rep. Wenstrup, Brad R. [R-OH-2]
Process start date: 2024-05-10
Voting date: 2024-09-09
Meeting no: 2
Voting no: 402
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

BIOSECURE Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_8333.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-05-10.

What are the main provisions?

Key points include:

  • Federal agencies are banned from procuring equipment or services from designated "biotechnology companies of concern" (e.g., BGI, WuXi AppTec).
  • Federal loan or grant money cannot be used by recipients to purchase or use services from these banned companies.
  • The ban is designed to safeguard US citizens' genetic and health data (multiomic data) from foreign adversaries.
  • Transition periods and specific waivers (e.g., for overseas healthcare) are included to manage the shift away from existing contracts.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Where is the official voting record?

The official roll call vote is recorded at: voting record

Who is the primary sponsor?

The primary sponsor is Rep. Wenstrup, Brad R. [R-OH-2].

What is the latest detailed status?

The latest detailed status is: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 306 - 81 (Roll no. 402). (text: CR H5051-5052)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Security Health Economy